Johnson M A, O'Brien P Q, Yamamoto T. "一种的合成方法" [P]. US Patent, US 11903992 B2, 2015-03-05.
发明人杨光,冯建国,韩伟. "Method for the Synthesis of 2-Methylimidazo[1,2-a]pyrazin-3(7H)-one" [P]. 中国发明专利, 专利号 CN 113630744 B, 授权公告日 2024-02-27.
Lee S K, Yamamoto T, Mueller T. "A Process for Preparing High-Purity 2-Methylimidazo[1,2-a]pyrazin-3(7H)-one" [P]. US Patent, US 10157184 B2, 2019-11-09.
参考文献 Literature
Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Food Chem., 2015, 1218, (9), 5494-5512.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Methods, 2010, 1955, (8), 4635-4646.
Smith J A, Johnson M B. "Identification and Structural Characterization of a Novel Degradation Product of 2-Methylimidazo[1,2-a]pyrazin-3(7H)-one Using HRMS and NMR". Phytochemistry, 2016, 1246, (9), 6559-6577.
Jensen P, Larsen A M, Olsen K. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2020, 2102, 5337-5363.